Yoichiro Tsukada

Summary

Affiliation: National Cancer Center
Country: Japan

Publications

  1. doi request reprint Are hospitals in Japan with larger patient volume treating younger and earlier-stage cancer patients? An analysis of hospital-based cancer registry data in Japan
    Yoichiro Tsukada
    Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center, Tokyo Department of Radiology, Toho University Omori Medical Center, Tokyo
    Jpn J Clin Oncol 45:719-26. 2015
  2. pmc Patterns of prescribing radiotherapy and bevacizumab in nationwide practice - analysis of 101 designated cancer care hospitals in Japan
    Yoichiro Tsukada
    Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center, 5 1 1 Tsukiji, Chuo Ku, Tokyo 104 0045, Japan Department of Radiology, Toho University Omori Medical Center, Tokyo, Japan
    J Radiat Res 57:157-63. 2016

Collaborators

Detail Information

Publications2

  1. doi request reprint Are hospitals in Japan with larger patient volume treating younger and earlier-stage cancer patients? An analysis of hospital-based cancer registry data in Japan
    Yoichiro Tsukada
    Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center, Tokyo Department of Radiology, Toho University Omori Medical Center, Tokyo
    Jpn J Clin Oncol 45:719-26. 2015
    ..We aimed to examine whether differences may exist by investigating the distribution of patients' stage and age across designated cancer treatment hospitals of varying patient volume across Japan...
  2. pmc Patterns of prescribing radiotherapy and bevacizumab in nationwide practice - analysis of 101 designated cancer care hospitals in Japan
    Yoichiro Tsukada
    Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center, 5 1 1 Tsukiji, Chuo Ku, Tokyo 104 0045, Japan Department of Radiology, Toho University Omori Medical Center, Tokyo, Japan
    J Radiat Res 57:157-63. 2016
    ..Many practices appeared to avoid the concurrent use of bevacizumab and radiation, but some provided concurrent therapy. Additional data are required to determine whether the avoidance of concurrent use should become a standard of care. ..